Intangible Assets

SBRA benefits from healthcare real-estate specialization and long-standing operator relationships, but these assets are not exclusive and peers such as OHI and WELL can target similar senior-housing and skilled-nursing tenants.

Regulatory and compliance know-how around healthcare facilities can support underwriting discipline, yet it does not create durable pricing power because comparable REITs can replicate the same expertise.

The portfolio’s value is tied to licensed care assets rather than proprietary IP, so tenant demand is driven more by facility economics than by SBRA-specific intangible assets versus peers.

Any brand advantage is limited because tenants and operators typically evaluate rent, coverage, and asset quality across multiple healthcare REITs, which keeps SBRA’s intangible moat below the strongest peer set.

Switching Costs

Leases and facility fit-outs create some friction for operators, but healthcare tenants can often renegotiate, refinance, or transition properties to other landlords over time, which limits SBRA’s retention advantage versus peers.

Because senior-housing and skilled-nursing operators are financially sensitive, switching is driven more by economics than by embedded technology or workflow dependence, so SBRA’s lock-in is weaker than in software-like models.

Relocation and licensing complexity can slow tenant moves, yet those frictions are industry-wide and therefore do not give SBRA a clear structural edge over OHI or WELL.

The company’s tenant relationships can support renewal stability, but the absence of high-cost integration or mission-critical platform dependence keeps switching costs moderate rather than strong.

Network Effects

SBRA does not operate a platform where more users increase value for other users, so there is no meaningful direct network effect.

Tenant demand for healthcare real estate is fragmented and local, which prevents the kind of ecosystem feedback loop that would compound moat strength versus peers.

Unlike marketplaces or data networks, SBRA’s asset base does not become more valuable simply because more operators lease from it, so network effects are not a source of durable advantage.

Peer comparison is unfavorable because OHI and WELL also lack strong network effects, leaving this factor structurally weak across the group rather than a differentiator for SBRA.

Cost Advantage

SBRA can sometimes source capital and manage assets at scale, but its TTM ROIC is negative and its ROCE is only modestly positive, which suggests limited evidence of a durable cost edge versus peers.

Healthcare REIT economics are heavily influenced by financing costs, asset mix, and tenant credit risk, and those inputs are broadly accessible to competitors such as OHI and WELL.

The company’s negative cash conversion cycle reflects the REIT structure rather than a unique operating advantage, so it does not translate into a clear pricing or margin edge.

Because peers can generally acquire similar assets and access similar capital markets, SBRA’s cost position appears competitive but not structurally superior.

Efficient Scale

Healthcare real estate has some local and regulatory complexity, which can create partial efficient-scale benefits in specific markets, but the industry remains large enough for multiple REITs to compete without monopoly-like economics.

SBRA’s scale can help spread overhead and underwriting costs, yet peers such as WELL and OHI also operate at meaningful scale, which limits SBRA’s relative advantage.

The business is not a natural monopoly because tenants can choose among several capital providers and property owners, so scale does not translate into peer-dependent control of the market.

Efficient scale is therefore a modest support for durability, but it is not strong enough to create exceptional pricing power or long-term retention versus peers.

Overall Score

SBRA has a defensible but not dominant moat: healthcare real-estate specialization and some lease friction support retention, but the company lacks strong network effects, proprietary intangible assets, or a clear cost advantage versus peers like OHI and WELL, so its competitive position looks durable only at a moderate level over the next 5–10 years.